In conclusion, since the downregulation of USP-7 activity and of its expression seems to be a crucial step in the modulation of MYCN amplified neuroblastoma cells, the discovery of STIRUR 41 effect on this enzyme paves the way for considering this chemical scaffold as a starting point for the development of new molecules active in the treatment of nervous system cancer. This evidence concerns the gene USP7 and nervous system cancer.